Clinical Trial Update: Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 study comparing cyclosporin dose reduction with cyclosporin elimination in kidney transplant recipients taking sir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Disease

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Kidney Disease | Phase 3 | Status: COMPLETED